X-Square Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Buy
6,824
+152
+2% +$35.4K 0.56% 62
2025
Q4
$1.38M Buy
6,672
+128
+2% +$25.3K 0.45% 67
2025
Q3
$1.21M Buy
6,544
+3
+0% +$514 0.38% 74
2025
Q2
$999K Buy
6,541
+125
+2% +$19.2K 0.36% 78
2025
Q1
$1.06M Buy
6,416
+576
+10% +$90.1K 0.46% 68
2024
Q4
$845K Sell
5,840
-50
-0.8% -$7.75K 0.35% 77
2024
Q3
$954K Buy
5,890
+179
+3% +$28.5K 0.42% 71
2024
Q2
$835K Buy
5,711
+32
+0.6% +$4.76K 0.39% 72
2024
Q1
$858K Buy
5,679
+71
+1% +$11.3K 0.41% 74
2023
Q4
$879K Sell
5,608
-243
-4% -$37.3K 0.49% 70
2023
Q3
$968K Hold
5,851
0.65% 57
2023
Q2
$968K Sell
5,851
-176
-3% -$28.4K 0.65% 57
2023
Q1
$934K Sell
6,027
-1,251
-17% -$202K 0.55% 61
2022
Q4
$1.29M Buy
7,278
+60
+0.8% +$10.4K 0.73% 51
2022
Q3
$1.18M Buy
7,218
+22
+0.3% +$3.72K 0.75% 53
2022
Q2
$1.28M Buy
7,196
+169
+2% +$30.1K 0.77% 50
2022
Q1
$1.25M Buy
7,027
+196
+3% +$33.4K 0.65% 60
2021
Q4
$1.17M Sell
6,831
-264
-4% -$43.2K 0.59% 61
2021
Q3
$1.14M Buy
7,095
+514
+8% +$87.7K 0.59% 59
2021
Q2
$1.08M Buy
6,581
+1,804
+38% +$299K 0.51% 61
2021
Q1
$786K Buy
4,777
+275
+6% +$44.5K 0.36% 75
2020
Q4
$708K Buy
4,502
+183
+4% +$27K 0.38% 67
2020
Q3
$643K Sell
4,319
-90
-2% -$13.3K 0.46% 60
2020
Q2
$619K Buy
4,409
+77
+2% +$11.2K 0.44% 53
2020
Q1
$568K Sell
4,332
-891
-17% -$126K 0.57% 45
2019
Q4
$762K Buy
5,223
+277
+6% +$37.6K 0.45% 40
2019
Q3
$640K Buy
4,946
+1,172
+31% +$154K 0.4% 40
2019
Q2
$526K Buy
3,774
+862
+30% +$119K 0.34% 45
2019
Q1
$408K Buy
2,912
+586
+25% +$78.5K 0.28% 54
2018
Q4
$300K Buy
2,326
+9
+0.4% +$1.25K 0.24% 60
2018
Q3
$320K Sell
2,317
-490
-17% -$65.1K 0.21% 62
2018
Q2
$341K Sell
2,807
-215
-7% -$26.8K 0.26% 54
2018
Q1
$387K Buy
3,022
+37
+1% +$5K 0.41% 47
2017
Q4
$417K Buy
+2,985
New +$416K 0.44% 49

Other funds holding JNJ

X-Square Capital's JNJ Position: Q1 2026 in Review

X-Square Capital increased its Johnson & Johnson (JNJ) stake by 2.3% in Q1 2026, buying an estimated $35.4K and bringing the position to 6,824 shares worth $1.67M. The position accounts for 0.56% of the portfolio, ranked #62.

X-Square Capital first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • X-Square Capital held 6,824 shares of Johnson & Johnson worth $1.67M as of Q1 2026.
  • X-Square Capital bought 152 Johnson & Johnson shares in Q1 2026, an estimated $35.4K.
  • Johnson & Johnson made up 0.56% of X-Square Capital's portfolio in Q1 2026, its #62 holding.
  • X-Square Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on X-Square Capital's 13F filing for Q1 2026, filed 15 May 2026.